Vietnam Law & Legal Forum Magazine is your gateway to the law of Vietnam

Official Gazette

Monday, May 10, 2021

Traditional drugs to be placed under stricter quality control

Updated: 07:58’ - 08/02/2021
Manufacturers would have to test the quality of medicinal materials, traditional medicaments as well as primary packaging of traditional drugs before putting them into production.

It is proposed by the Ministry of Health (MoH) in a draft circular on the quality of medicinal materials, traditional medicaments and traditional drugs during trading, market circulation and use.

Traditional physician Nguyen Van Manh, Chairman of the Traditional Medicine Association of Uong Bi City, makes up prescriptions for patients__Photo: Internet

The MoH especially proposes the application of good manufacture practice principles and standards throughout the process of trading in medicinal materials, traditional medicaments and traditional drugs in conformity with traders’ business activities.

Particularly, traders would have to inspect and control the quality of traditional drugs as well as medicinal materials and other materials used for manufacture of traditional drugs at their establishments. They would also be required to conduct testing to evaluate the quality of traditional drugs and medicinal materials and other materials used for manufacture of traditional drugs during the process of manufacture, delivery and circulation.

In order to ensure traceability of origin and control the whole transportation routes and storage conditions of traditional drugs, medicinal materials, traditional medicaments, and other materials used in manufacture of traditional drugs, the draft requires traders to keep all dossiers, documents and information relating to the purchase, sale, import, distribution or circulation of medicinal materials, traditional medicaments and traditional drugs.

Medicinal materials, traditional medicaments and traditional drugs used in healthcare facilities must meet pharmacopoeial standards or in-house standards as announced.  

Healthcare facility directors must conduct periodical quality inspection at least every three months and unscheduled quality inspection in their facilities. If detecting factors likely to affect the quality of medicinal materials and traditional drugs, healthcare facilities would have to send samples of such medicinal materials and traditional drugs to licensed labs for testing.- (VLLF)

 

Send Us Your Comments:

See also: